There is CDKN2B-AS1, known also as ANRIL, is up-regulated in RCC tissue which corresponds with our results (Angenard et al. 2019; Dasgupta et al. 2020; Xie et al. 2021) and there are even some single nucleotide polymorphisms identified which are typically associated with RCC (Li et al. 2014). This evidence concerns the gene CDKN2B and renal cell carcinoma.